Vyas Jigar, Patel Jayvadan, Jain D. A.


Solid  dispersions  (SDs)  of  modafinil  (MDF)  were  prepared using polyethyleneglycols (PEGs), in 1;1, 1;2 and 1;4 proportions by  fusion,  solvent  evaporation  and  physical  mixing  method. Differential  scanning  calorimetry  (DSC)  and  X-ray  powder diffractometry (XRD)  were  used to examine the physical state  of the  drug.  The  data  from  the  XRD  showed  that  the  drug  was converted  to  amorphous  form  as  the  number  and  intensity  of peaks  were  decreased  in  solid  dispersion  as  compared  to  pure drug and physical mixture of drug and carrier. DSC thermograms also  confirmed  the  change  in  physical  state  of  the  drug  as  the peaks were altered or disappeared. With the  highest  ratio of the carriers (1:4), the drug  solubility was enhanced by 38.68, 34.78 and 9.29 folds in solvent evaporation, fusion and physical mixing methods  respectively.  Solid  dispersion  batch  S6  containing drug:PEG6000  in  1:4,  was  selected  to  be  formulated  as  tablet (batch  TS6)  and  evaluated  for in  vitro drug  dissolution  &  six month  stability.  An  increased  dissolution  rate  of  modafinil  was observed  from  SDs  and  PMs,  as  compared  to  pure  crystalline drug.  The  dissolution  rate  of  modafinil  from  its  PMs  or  SDs increased with an increasing amount of polymer.

Key  words:  Fusion,  solvent  evaporation,  physical  mixture,  in  vitro dissolution, characterization.


Full Text:



Ahuja, B. C., Katare, O. P. and Singh, B., 2007, Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers, Eur. J. Pharm. Biopharm., 65, 26-38.

Ambike, A. A., Mahadik, K. T. and Paradkar, A., 2005, Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations, Pharm. Res.,22, 990-998.

Chiou, W. L. and Riegelman, S., 1971, Pharmaceutical applications of solid dispersion systems, J. Pharm. Sci., 60, 1281-1302.

Chiou, W. L., and Riegelman, S., 1969, Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin, J. Pharm. Sci.,60, 1281-1302.

Craig, D. Q. M., 2002, The mechanism of drug release from solid dispersions in water soluble polymers, Int. J. Pharm., 231, 131-144.

Ford, J. L., 1986, The current status of solid dispersions. Pharm. Acta Helv., 61 69-88.

Hajratwala, B. R., 1974, Dissolution of solid dispersion systems, Aust. J. Pharm. Sci., NS3, 101-109.

Hancock, B. C., 2002, Disordered drug delivery: destiny, dynamics and the Deborah number, J. Pharm. Pharmacol.,54, 737-746.

Jacobs, M. J., McIntyre, B. T., Parikh, A. and Patel, P. R., 2002, Pharmaceutical solutions of modafinil compounds, U.S. Pat. 6,919,378.

Khawam, A. and Flanagan, D., 2006, Solidstate kinetic model: basics and mathematical fundamentals, J. Phys. Chem. B., 110, 17315-17328.

Leuner, C., and Dressman, J., 2000, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm., 50, 47-60.

Marsac, P. J., Konno, H. and Taylor, L. S., 2006a, A comparison of the physical stability of amorphous felodipine and nifedipine systems, Pharm. Res., 23, 2306-2315.

Marsac, P. J., Shamblin, S. L. and Taylor, L. S., 2006b, Theoretical and practical approaches for prediction of drug–polymer miscibility and solubility, Pharm. Res., 23, 2417-2426.

Mayersohn, M. and Gibaldi, M., 1966, New method of solid state dispersion for increasing dissolution rates, J. Pharm. Sci., 55, 1323-1324.

Minzenberg, M. J. and Carter, C. S., 2007, Modafinil: A Review of Neurochemical Actions and Effects on Cognition, Neuropsychopharmacology, 33, 1-26.

Vippagunta, S. R., Wang, Z., Hornung, S. and Krill, S., 2007, Factors affecting the formation of eutectic solid dispersions and their dissolution behavior, J. Pharm. Sci., 96, 294-304.

DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp209-215


  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:


analytics View My Stats